Bandingkan Harga & Kinerja Charlie Hospital Semarang Tbk. (RSCH) vs Reksa Dana Danareksa ETF Indonesia Top 40 (XDIF)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Charlie Hospital Semarang Tbk. dan Reksa Dana Danareksa ETF Indonesia Top 40: Charlie Hospital Semarang Tbk. diperdagangkan di Rp270 (kapitalisasi pasar 742 M, volume 24 jam 29,45 jt), sedangkan Reksa Dana Danareksa ETF Indonesia Top 40 diperdagangkan di Rp422 (kapitalisasi pasar 29,39 M, volume 24 jam 300). Perbedaan utamanya: Charlie Hospital Semarang Tbk. jauh lebih besar — sekitar 25,2× kapitalisasi pasar Reksa Dana Danareksa ETF Indonesia Top 40, dan Charlie Hospital Semarang Tbk. lebih aktif diperdagangkan (29,45 jt vs 300). Mana yang lebih baik tergantung tujuan investasimu.
| RSCH | XDIF | |
|---|---|---|
Kapitalisasi Pasar | 742 M | 29,39 M |
Volume | 29,45 jt | 300 |
Lot | 294,49 rb | 3 |
Perputaran | 8,14 M | 126,7 rb |
Harga Rata-rata | 276,35 | 422,33 |
Nilai Transaksi | 8,14 M | 126,7 rb |
Harga Ekuilibrium Indikatif | 270 | — |
Volume Ekuilibrium Indikatif | 103 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →
